Menu
Not yet recruiting NCT06637982

Extended Platelet Rich Fibrin in Mandibular Alveolar Ridge Splitting

No phase Interventional Ridge Splitting

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: ridge splitting with the use of allograft and pericardium membrane, ridge splitting with the use of extended platelet rich fibrin.
Who it may be relevant to
Registry conditions: Ridge Splitting. Basic parameters: 18 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Extended Platelet Rich Fibrin in Mandibular Alveolar Ridge Splitting With Simultaneous Implant Placement

Overview

Thirty two healthy implants will be selected from the outpatient clinic of the oral and maxillofacial department of Mansoura university to be included in this study for replacement of lost posterior teeth with limited bone width.

Interventions

  • Procedure ridge splitting with the use of allograft and pericardium membrane
    ridge splitting with the use of allograft and pericardium membrane
  • Procedure ridge splitting with the use of extended platelet rich fibrin
    ridge splitting with the use of extended platelet rich fibrin

Primary outcome measures

  • implant stability [Time frame: 9 months]
  • alveolar ridge width [Time frame: 9 months]

Eligibility criteria

Inclusion criteria

  • Patient age 18 years old and older.
  • Patient's cooperation, motivation and good oral hygiene.
  • Atrophic posterior mandible of horizontal alveolar dimension range between 3 - 6 mm at the crest, with minimum 10 mm vertical height from the alveolar crest to the superior border of the inferior alveolar canal.
  • Absence of undercuts in buccal aspect of the ridge.
  • Favorable occlusion and no parafunctional habits.
  • Patients able to comply with the required recall visits.
  • No gender preface in selection of the patients.
  • Acceptable inter-arch space for the future prosthesis.

Exclusion criteria

  • Any pathological condition at the site of surgery.
  • Patients with systemic diseases that contra-indicate the surgical procedure such as uncontrolled diabetes mellitus, bleeding disorders, serious osseous disorders, and mental disorders.
  • Patient taking drugs that could affect bone healing process as immunosuppressive drugs and bisphosphonates.
  • Heavy smoking and alcoholism.
  • Parafunctional habits such as bruxism and clenching.
  • Signs of acute infection or pus discharge.
  • Untreated periodontal disease or bad oral hygiene.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Triple blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Mansoura University — Mansoura, Egypt

Identifiers

NCT: NCT06637982 · A0302024OS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗